Med-IQ

Course Listings: Oncology

All Results (13)
Format: Live Events (0) Online Activities (13)

The Use of Molecular Biomarkers in Colon Cancer

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: In this Med-IQ Express activity, faculty describe the rationale for using molecular markers in the diagnosis and prognosis of colon cancer.


Tumor Lysis Syndrome in a Rapidly Evolving Treatment Landscape

View Course

Format: E-Publication

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This interactive, digital CME publication integrates current clinical evidence and an algorithmic approach to assessing the risk of and planning prophylaxis for tumor lysis syndrome (TLS) in patients for whom an anticancer therapeutic strategy is being developed. Expert insight on responses to patient-case scenarios from a national survey help highlight best…More


Case Simulations in Optimizing Treatment Plans for Metastatic Pancreatic Cancer

View Course

Format: Simulation

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: In this video-enhanced, CME-certified, case-based simulation, clinicians are challenged to select appropriate therapies for two patients with metastatic pancreatic adenocarcinoma. Throughout the activity, clinicians must consider multiple clinical factors including patient- and disease-related characteristics, patient preferences, and the latest evidence to…More


Improving Multiple Myeloma Care in a Rapidly Evolving Field

View Course

Format: Webcast

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: This CME Webcast explores clinical management strategies for multiple myeloma. Experts in the field use patient cases to discuss current clinical evidence and treatment guidelines for newly diagnosed and relapsed/refractory disease, with a focus on patient-, disease-, and treatment-related factors that guide therapeutic decisions.


Addressing Barriers to Advanced NSCLC Care

View Resource

Format: Audioconference

Course Description: In these free, personalized audioconferences, clinicians speak with nationally renowned experts in advanced NSCLC. During this live conversation, participants identify barriers to optimal advanced NSCLC treatment in their own practices and receive guidance on developing strategies to overcome them. The purpose of this initiative is to identify gaps, barriers,…More

Note: This material is not accredited for CME and, therefore, does not offer any CME/CE credit.


Key Concepts in the Ever-Evolving Therapeutic Landscape of Advanced HER2-Positive and Triple-Negative Breast Cancer

View Course

Format: E-publication

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This interactive publication examines current evidence and guideline recommendations for the treatment of HER2-positive and triple-negative breast cancer. It also features audio clips of expert faculty perspectives regarding key findings and clinical evidence from the latest immunotherapy trials to help oncologists apply these data when developing…More


Recognizing Gaucher’s Disease in the Hematology Clinic

View Course

Format: Presentation Points

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This transcript-based, CME-certified Presentation Points publication summarizes a satellite symposium presented by Pramod K. Mistry, MD, PhD, FRCP, and Neal J. Weinreb, MD, FACP, nationally renowned experts in Gaucher’s disease (GD) type 1. Faculty present strategies for recognizing symptoms early in the disease course and discuss the implications of…More


Case Simulations in Metastatic Melanoma: Navigating Complex Treatment Decisions

View Course

Format: Simulation

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: In these video-enhanced, CME-certified, case-based simulations, clinicians are challenged to select first- and subsequent-line treatment regimens for two fictional patients with stage IV melanoma. Throughout the activity, clinicians must consider patient- and tumor-related characteristics, patient preferences, and contemporary evidence to make appropriate…More


Helping Clinicians Navigate the Complexities of Advanced NSCLC Treatment

View Course

Format: Presentation Points

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: This CME-certified Presentation Points is a slightly abridged transcript of a presentation given by Drs. H Jack West and Corey Langer on the treatment for advanced non–small cell lung cancer (NSCLC). These experts discussed biomarker testing to inform optimal treatment decisions, as well as the latest scientific evidence on the role of anti-angiogenic agents…More


Managing CLL With Oral Agents

View Course

Format: Webinar

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 California Board of Registered Nursing (CBRN)

Course Description: This activity brings together two nationally recognized experts to discuss the practical considerations of managing CLL with oral agents. It explores the benefits and challenges of oral CLL therapies, discusses strategies for monitoring and managing adverse events, and addresses barriers to adherence.


Sequencing Treatment for Metastatic Castration-Resistant Prostate Cancer: How to Match Patients to the Right Therapy

View Course

Format: E-publication

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: This interactive, audio-enhanced online publication discusses available treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) in both the first- and second-line settings. Additionally, case studies from a national survey of oncologists and urologists are presented to illuminate common practice challenges. Expert faculty…More


Integrating Advances and Optimizing Contemporary Strategies in Renal Cell Carcinoma

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This CME-certified publication reviews the treatment options for patients with metastatic renal cell carcinoma (mRCC), discusses the latest clinical evidence for available therapeutic options, and explores the patient- and disease-related factors that should be considered when planning mRCC treatment.


Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer: A Focus on Colony-Stimulating Factors

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This activity presents the latest guideline recommendations for identifying patients with breast cancer who have a risk of developing chemotherapy-induced neutropenia. It also provides guideline-based strategies for initiating preventive treatment, with a special focus on evidence associated with available and emerging granulocyte colony-stimulating factors.